跳至主要内容
临床试验/CTRI/2025/06/088778
CTRI/2025/06/088778尚未招募不适用

Comparison of Acetate-based, Lactate-based and Multiple Electrolyte Solution versus saline (MeSLAc trial) in Dengue shock – A multicenter randomized controlled trial

All India Institute of Medical Sciences, New Delhi1 个研究点 分布在 1 个国家目标入组 560 人开始时间: 2025年12月18日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
560
试验地点
1
主要终点
Proportion of children with Major Adverse Kidney events - new onset or progressive AKI, in-hospital mortality, new renal replacement therapy, or persistent renal dysfunction at 30 days

研究概览

简要总结

Septic shock and dengue shock syndrome are important cause of mortality and morbidity in children. Fluid resuscitation is a key intervention in the management of septic shock and dengue shock syndrome. The purpose of fluid resuscitation is to replenish the intravascular volume in order to improve microcirculation and tissue perfusion, and maintain normal cardiac index.

The WHO guideline issued in 2009 recommends prompt administration of crystalloids (saline or Ringers lactate) in patients with dengue shock followed by sequential tapering of the crystalloid regimen. Saline has been routinely used as bolus therapy in severe dengue in the first hour as it is inexpensive and readily available with an efficacy similar to colloids with respect to shock resolution and mortality.

Normal saline has its own set of undesired physicochemical actions. It is slightly hypertonic to plasma and is both hypernatremic as well as hyperchloremic relative to plasma. Emerging data strongly indicate the increased incidence of hyperchloremic metabolic acidosis and consequently, acute kidney injury associated with infusion of boluses of normal saline in critically ill adults and children in shock. Balanced crystalloids (BC) have a composition resembling plasma with a lower chloride concentration than saline.  Some balanced crystalloids (e.g., multiple electrolytes solution (MES) also known as Plasma-Lyte A, lactated Ringer’s, Ringer’s acetate) have been reported to be associated with decreased risk of metabolic disturbances such as hyperchloremia and metabolic acidosis as compared to saline in children from diverse patient settings.

In children, in a recently concluded large multicentre trial by our group comparing balanced crystalloids and saline, there was significant reduction in the incidence of AKI (21% vs. 39%) and other metabolic derangements like hyperchloremia and metabolic acidosis with the use of balanced crystalloids. Even though the fluids were mainly used as bolus therapy and not maintenance, the protective effect on kidneys and metabolic parameters was observed with the use of BC.

Among the balanced crystalloids, Ringers Lactate is widely used in dengue for ongoing fluid therapy although there is no robust evidence to support its use. There are different BCs available in the market now apart from Ringers lactate such as Ringers acetate and Multiple electrolyte solution. There are few studies comparing various types of colloids with saline and Ringers lactate but none comparing the various crystalloids alone. Our rationale for conducting the present study is guided by lack of pediatric data comparing various crystalloids in dengue shock.  It needs to be seen which of these crystalloids have a better metabolic profile and are reno protective as compared to saline in dengue.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
2.00 Month(s) 至 15.00 Year(s)(—)
性别
All

入选标准

  • Children 2 month to less than 17 years with features of Dengue shock defined as children with probable dengue fever ; a positive test by rapid diagnostic test; and have at least two clinical signs of decreased perfusion with or without hypotension.

排除标准

  • Children with culture positive sepsis or suspected septic shock Children receiving fluid boluses before enrollment Children with cardiogenic shock.
  • Children whose parents refuse to give an informed consent.

结局指标

主要结局

Proportion of children with Major Adverse Kidney events - new onset or progressive AKI, in-hospital mortality, new renal replacement therapy, or persistent renal dysfunction at 30 days

时间窗: Within 30 days of enrollment

次要结局

  • Mortality(Till day 30)
  • Proportion of children with hyperchloremia(In the first 7 days)
  • Proportion of children attaining shock resolution(In first 24 hours)

研究者

发起方
All India Institute of Medical Sciences, New Delhi
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Jhuma Sankar

All India Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验